Nikki Nollen, PhD, MA

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Nikki Nollen, PhD, MA sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 2 completed later-stage tilt upper quartile by trial count

Nikki Nollen, PhD, MA: 3 sponsored US clinical trials, 1 recruiting.

Nikki Nollen, PhD, MA sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smokers, with 1 trials.

Upper-quartile sponsor footprint

Nikki Nollen, PhD, MA sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Where Nikki Nollen, PhD, MA enrollment is open (later-stage tilt)

1 recruiting of 3 indexed (33% open); 2 completed (67%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Smokers (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Nikki Nollen, PhD, MA: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Nikki Nollen, PhD, MA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Nikki Nollen, PhD, MA10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Nikki Nollen, PhD, MA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nikki Nollen, PhD, MA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this Nikki Nollen, PhD, MA page

3 registered trials is a research-attention snapshot, not an endorsement of Nikki Nollen, PhD, MA or any single study.

  • 1 of Nikki Nollen, PhD, MA's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Smokers is the condition Nikki Nollen, PhD, MA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smokers trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nikki Nollen, PhD, MA pipeline card: 3 registered trials from official public datasets.Report a data error.